Shinjini Singh

Shinjini Singh, PhD, is currently a Global CTA II at IQVIA since July 2022 and has served as an Editorial Board Member for several prestigious journals including OMSP International and Cientperiodique Medicine. With a strong background in oncology, Shinjini Singh holds the position of Executive Editor and Reviewer for multiple publications such as Molecular Cancer Therapeutics and Frontiers in Molecular Biosciences. Previous roles include Clinical Research Coordinator at Cleveland Clinic Lerner Research Institute and Clinical Research Regulatory Specialist at University Hospitals. Shinjini Singh earned a PhD in Biotechnology-Medicine from Banaras Hindu University and holds an MSc in Biotechnology and a BSc in Zoology, Botany, and Chemistry from Deendayal Upadhyay Gorakhpur University.